Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2015

View Archived Issues

Transformed porcine mammary epithelial cells form xenograft tumors in mice

MAF is a biomarker of breast cancer bone metastasis

MedImmune initiates phase I study of MEDI-9197 for solid tumor cancers

PTP1B shows promise for the improvement of islet graft revascularization

Daiichi Sankyo divulges EZH1/EZH2 inhibitors

MyoKardia provides update on two phase I trials of MYK-461

Osiris begins phase III trial of OTI-15-01 in chronic diabetic foot wounds

Abeona Therapeutics forms license agreement for next-generation AAV delivery vector

Serendex reports results from phase I trial of inhaled GM-CSF

GreenPeptide files IND for cancer peptide vaccine GRN-1201

FDA grants priority review to Daklinza supplemental NDAs

Avelumab receives FDA fast track designation for metastatic Merkel cell carcinoma

Novel insulin mutation linked to autosomal dominant diabetes

Nektar submits IND for NKTR-214 to treat solid tumor malignancies

Paranta Biosciences starts phase I trial of inhaled follistatin

Bristol-Myers Squibb introduces NS5B inhibitors

Capella Therapeutics patents EGFR inhibitors

Bayer Schering Pharma divulges Wnt signaling inhibitors

Agios presents glutaminase inhibitors

MD Anderson and Theraclone partner to launch new company OncoResponse

DeNovo Sciences and bioTheranostics to collaborate on detection of cancer biomarkers in blood

Octapharma acquires license to Glycotope's recombinant technology, takes shareholding

FDA grants rare pediatric disease designation to deflazacort for DMD

Nivalis announces topline results from phase Ib study of N-91115 in cystic fibrosis

RATHER collaboration reports on phase II trial of taselisib in hard-to-treat breast cancers

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...